EZH2 and endometrial cancer: Multivariate analysis identified EZH2 expression as an independent factor for poor prognosis in endometrial cancer with endometrioid histology (HR = 5.31, 95% CI = 1.04–96.9, P = 0.0442) in the TMA data set (Supplementary Table 5).